{"title":"Preliminary study in genetic polymorphism of hOGG1 and risk factor for thyroid cancer in Indonesia","authors":"H. N. E. Surniyantoro, N. Hidayati","doi":"10.1063/5.0047941","DOIUrl":null,"url":null,"abstract":"The human 8-oxoguanine DNA N-glycosylase-1 (hOGG1) is the most important DNA repair enzyme in base excision repair (BER) pathways and has been reported to have a relationship with the risk of developing various cancers. The study was aimed to assess the genetic polymorphism of hOGG1 as a risk factor for thyroid cancer. A total of 19 participants were enrolled in this study, consisted of ten thyroid cancer patients as a case group and nine non-cancer patients as a control group. Examination of hOGG1 genotype was carried out by using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method and statistical analysis using a Chi-square test. In this study, we found the frequency of hOGG1 genetic polymorphism was not significantly different between cancer patients and control groups and we predict that the polymorphism was not a risk factor for cancer (P>0.05). Results showed the frequency of G allele (mutant) was 0.5 in the case group and 0.33 in the control group. We found that frequency of hOGG1 genetic polymorphism was not significantly different between cancer patients and control groups and this work predicts that the polymorphism was not a risk factor for thyroid cancer. In further studies, it is necessary to assess genetic polymorphisms in populations with controlled non-genetic factors, such as diet, lifestyle, and environmental factor. The relatively small sample size must be considered as a limitation of the study, and thus further research is needed in different populations with larger sample sizes.","PeriodicalId":379310,"journal":{"name":"PROCEEDINGS OF THE INTERNATIONAL CONFERENCE AND SCHOOL ON PHYSICS IN MEDICINE AND BIOSYSTEM (ICSPMB): Physics Contribution in Medicine and Biomedical Applications","volume":"142 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PROCEEDINGS OF THE INTERNATIONAL CONFERENCE AND SCHOOL ON PHYSICS IN MEDICINE AND BIOSYSTEM (ICSPMB): Physics Contribution in Medicine and Biomedical Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1063/5.0047941","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The human 8-oxoguanine DNA N-glycosylase-1 (hOGG1) is the most important DNA repair enzyme in base excision repair (BER) pathways and has been reported to have a relationship with the risk of developing various cancers. The study was aimed to assess the genetic polymorphism of hOGG1 as a risk factor for thyroid cancer. A total of 19 participants were enrolled in this study, consisted of ten thyroid cancer patients as a case group and nine non-cancer patients as a control group. Examination of hOGG1 genotype was carried out by using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method and statistical analysis using a Chi-square test. In this study, we found the frequency of hOGG1 genetic polymorphism was not significantly different between cancer patients and control groups and we predict that the polymorphism was not a risk factor for cancer (P>0.05). Results showed the frequency of G allele (mutant) was 0.5 in the case group and 0.33 in the control group. We found that frequency of hOGG1 genetic polymorphism was not significantly different between cancer patients and control groups and this work predicts that the polymorphism was not a risk factor for thyroid cancer. In further studies, it is necessary to assess genetic polymorphisms in populations with controlled non-genetic factors, such as diet, lifestyle, and environmental factor. The relatively small sample size must be considered as a limitation of the study, and thus further research is needed in different populations with larger sample sizes.
人类8-氧鸟嘌呤DNA n -糖基化酶-1 (hOGG1)是碱基切除修复(BER)途径中最重要的DNA修复酶,已被报道与多种癌症的发生风险有关。该研究旨在评估hOGG1基因多态性作为甲状腺癌的危险因素。共有19名参与者参加了这项研究,其中10名甲状腺癌患者作为病例组,9名非癌症患者作为对照组。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法检测hOGG1基因型,采用卡方检验进行统计学分析。在本研究中,我们发现hOGG1基因多态性的频率在癌症患者和对照组之间没有显著差异,我们预测该多态性不是癌症的危险因素(P>0.05)。结果显示,病例组G等位基因(突变)频率为0.5,对照组为0.33。我们发现hOGG1基因多态性的频率在癌症患者和对照组之间没有显著差异,这项工作预测多态性不是甲状腺癌的危险因素。在进一步的研究中,有必要在饮食、生活方式和环境等非遗传因素可控的人群中评估遗传多态性。相对较小的样本量必须被认为是研究的局限性,因此需要在更大样本量的不同人群中进行进一步的研究。